{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:25:31Z","timestamp":1787027131698,"version":"build-2736575974"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:bold>Objectives:<\/jats:bold>\n                    To evaluate whether novel biomarkers of renal injury, serum HE4 and NT-proBNP could predict acute kidney injury (AKI) on chronic kidney disease (CKD) (A on C) and assess the specificity and efficiency of serum creatinine (SCr), HE4 and NT-proBNP in identifying potential AKI. Meanwhile, the potential early-warning value of HE4 and NT-proBNP in CKD patients was explored.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    We performed a single-center, retrospective cohort study of 187 adult CKD patients. 32 AKI (grades 1\u20132) patients with pre-existing CKD (stages 3\u20135) were Group 1, 59 patients of CKD (stages 4\u20135) were Group 2. Another 96 patients of CKD (stages 1\u20133) were Group 3. All patients received general treatments, Group 1 patients received Chinese herb formulation (Chuan Huang Fang-\u2161, CHF-\u2161) simultaneously. These 155 CKD (stages 1\u20135) without AKI patients were observed for descriptive analysis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    HE4 in Group 1 (860.63 \u00b1 385.40) was higher than that in Group 2 (673.86 \u00b1 283.58) before treatments. BUN, SCr, UA, NGAL, IL18, HE4 and NT-proBNP in Group 1 were lower, while eGFR was higher (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.01, after vs. before treatments). In Group 1, both HE4 and NT-proBNP were positively correlated with SCr (respectively\n                    <jats:italic>r<\/jats:italic>\n                    = 0.549, 0.464) before treatments. The diagnostic performance of serum HE4 and NT-proBNP for A on C was 351.5\u00a0pmol\/L, 274.5\u00a0pg\/mL as the optimal cutoff value Area Under Curve (AUC) 0.860 (95% CI: 0.808 \u2013 0.913,\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.001), [AUC 0.775 (95% CI: 0.697 \u2013 0.853,\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.001), with a sensitivity and specificity of 100% and 66.5%, 87.5% and 48.8%, respectively]. In Group 2, serum HE4 was correlated with SCr (\n                    <jats:italic>r<\/jats:italic>\n                    = 0.682,\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.01) before treatments. Serum HE4 and NT-proBNP were elevated in advanced CKD stages, and were increased as CKD stages progressed with statistical significance.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    This work indicated serum HE4 and NT-proBNP should elevate in A on C and CKD patients, HE4 is positively correlated with the disease severity, and patients with higher HE4 and NT-proBNP usually have poorer prognosis. Thus, serum HE4 and NT-proBNP are impactful predictors of A on C. Additionally, serum HE4 and NT-proBNP have the potential to evaluate clinical efficacy of A on C.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2023.1269311","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:53:06Z","timestamp":1694393586000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Elevation of serum human epididymis protein 4 (HE4) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) as predicting factors for the occurrence of acute kidney injury on chronic kidney disease: a single-center retrospective self-control study"],"prefix":"10.3389","volume":"14","author":[{"given":"Jinye","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1111\/bph.16096","article-title":"Jumonji domain-containing protein-3 (JMJD3) promotes myeloid fibroblast activation and macrophage polarization in kidney fibrosis","volume":"180","author":"An","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"B2","first-page":"2767","article-title":"The relationship between serum HE4 and disease progression stake in patients with CKD after renal transplantation and its diagnostic value","volume":"40","author":"Bai","year":"2019","journal-title":"Int. J. Lab. Med."},{"key":"B3","first-page":"625","article-title":"Research progress on risk factors of chronic kidney disease complicated with acute kidney injury and the mechanism of influencing kidney repair","volume":"18","author":"Cao","year":"2023","journal-title":"Chin. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute kidney injury and chronic kidney disease as interconnected syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12877-021-02698-6","article-title":"Correction to: Ultrasound-guided supra-inguinal fascia iliaca compartment block for older adults admitted to the emergency department with hip fracture: A randomized controlled, double-blind clinical trial","volume":"9","author":"Chen","year":"","journal-title":"Integr. Med. Nephrol. Androl."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1099642","DOI":"10.1155\/2022\/1099642","article-title":"Efficacy and safety of chuan Huang Fang combining reduced glutathione in treating acute kidney injury (grades 1-2) on chronic kidney disease (stages 2-4): Study protocol for a multicenter randomized controlled clinical trial","volume":"2022","author":"Chen","year":"","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e7824","DOI":"10.1097\/MD.0000000000007824","article-title":"Potential association between elevated serum human epididymis protein 4 and renal fibrosis A systemic review and meta-analysis","volume":"96","author":"Chen","year":"2017","journal-title":"Med. Baltim."},{"key":"B8","doi-asserted-by":"publisher","first-page":"969107","DOI":"10.3389\/fphar.2022.969107","article-title":"Chuan Huang Fang combining reduced glutathione in treating acute kidney injury (grades 1-2) on chronic kidney disease (stages 2-4): A multicenter randomized controlled clinical trial","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jfma.2015.10.015","article-title":"The role of brain natriuretic peptide in predicting renal outcome and fluid management in critically ill patients","volume":"114","author":"Chou","year":"2015","journal-title":"J. Formos. Med. Assoc."},{"key":"B10","first-page":"657","article-title":"The association between BNP and ultrafiltration in patients with CRRT","volume":"12","author":"Cui","year":"2013","journal-title":"Chin. J. Blood Purif."},{"key":"B11","doi-asserted-by":"publisher","first-page":"951629","DOI":"10.4061\/2011\/951629","article-title":"B-type natriuretic Peptide in the critically ill with acute kidney injury","volume":"2011","author":"de Cal","year":"2011","journal-title":"Int. J. Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1159\/000488829","article-title":"Metabolic syndrome severity and risk of CKD and worsened GFR: The jackson heart study","volume":"43","author":"DeBoer","year":"2018","journal-title":"Kidney Blood Press Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.16305\/j.1007-1334.2013.03.023","article-title":"Research on Radix et Rhizoma Rhei-Rhizoma Ligustici Chuanxiong restraining renal tubular epithelial cell apoptosis in contrast-induced nephropathy rats","volume":"47","author":"Gong","year":"2013","journal-title":"Shanghai J. Trad. Chin. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.16306\/j.1008-861x.2017.06.014","article-title":"Effects of Couplet Medicines of Prepared Radix et Rhizoma Rhei-Rhizoma Ligustici Chuanxiong on Nrf2\/HO-1 Signaling Pathway in Renal Tissue of Contrast induced Nephropathy Rats","volume":"31","author":"Gong","year":"2017","journal-title":"J. Shanghai Univ. Trad. Chin. Med. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.15932\/j.0253-9713.2019.12.009","article-title":"Effect of Chuanhuang Fang on apoptosis of renal tubular epithelial cells in rats with trivalent arsenic nephrotoxicity","volume":"41","author":"Gong","year":"2019","journal-title":"Beijing Med. J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.16306\/j.1008-861x.2020.01.002","article-title":"Effects of Chuanhuang Decoction on renal function and oxidative stress in patients of chronic kidney disease at stage 2-4 complicated with acute kidney injury","volume":"34","author":"Gong","year":"2020","journal-title":"J. Shanghai Univ. Trad. Chin. Med. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.16306\/j.1008-861x.2021.06.002","article-title":"Effects of Chuanhuang Formula combined with prostaglandin E1 in treating patients of chronic kidney disease complicated with acute kidney injury and its influence on NLRP3","volume":"34","author":"Gong","year":"2021","journal-title":"J. Shanghai Univ. Trad. Chin. Med. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10157-016-1243-2","article-title":"Incidence of acute kidney injury among patients with chronic kidney disease: A single-center retrospective database analysis","volume":"21","author":"Hatakeyama","year":"2017","journal-title":"Clin. Exp. Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jconrel.2016.03.001","article-title":"Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy","volume":"30","author":"He","year":"2016","journal-title":"J. Chin. Pract. Diagn Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.kint.2017.06.030","article-title":"AKI on CKD: Heightened injury, suppressed repair, and the underlying mechanisms","volume":"92","author":"He","year":"2017","journal-title":"Kidney Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e3674","DOI":"10.1097\/md.0000000000003674","article-title":"Incidence, outcomes, and risk factors of community-acquired and hospital-acquired acute kidney injury: A retrospective cohort study","volume":"95","author":"Hsu","year":"2016","journal-title":"Med. Baltim."},{"key":"B22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/labmed\/lmz041","article-title":"Human epididymis protein 4 as an indicator of acute heart failure in patients with chronic kidney disease","volume":"51","author":"Huang","year":"2020","journal-title":"Lab. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1186\/s12879-018-3569-8","article-title":"Multi-systemic melioidosis: A clinical, neurological, and radiological case study from hainan province, China","volume":"17","author":"Huang","year":"2018","journal-title":"Chin. J. Blood Purif."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.3390\/cells10113057","article-title":"STAT6 deficiency attenuates myeloid fibroblast activation and macrophage polarization in experimental folic acid nephropathy","volume":"10","author":"Jiao","year":"","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","first-page":"735014","DOI":"10.3389\/fimmu.2021.735014","article-title":"Pharmacological inhibition of STAT6 ameliorates myeloid fibroblast activation and alternative macrophage polarization in renal fibrosis","volume":"12","author":"Jiao","year":"","journal-title":"Front. Immunol."},{"key":"B26","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int. Suppl."},{"key":"B27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nm.2989","article-title":"Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1101036","DOI":"10.3389\/fphar.2023.1101036","article-title":"Bibliometric and visualization analysis of kidney repair associated with acute kidney injury from 2002 to 2022","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B29","first-page":"789","article-title":"Clinical value of serum human epididymal protein 4 in the diagnosis of chronic kidney disease","volume":"20","author":"Li","year":"2022","journal-title":"Chin. J. General Pract."},{"key":"B30","first-page":"12","article-title":"Curative effect and mechanism of rhubarb in treating chronic renal failure","author":"Li","year":"1991","journal-title":"J. Clin. inter Med."},{"key":"B31","first-page":"3322","article-title":"The risk factors and prognosis of patients with acute kidney injury on the basis of chronic kidney disease","volume":"40","author":"Liu","year":"2018","journal-title":"Hebei Med. J."},{"key":"B32","first-page":"89","article-title":"Progress in diagnosis and treatment of acute kidney injury with Chinese and Western medicine","volume":"49","author":"Liu","year":"2021","journal-title":"Acta Chin. Med. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cca.2018.05.006","article-title":"Serum human epididymis secretory protein 4 as a potential biomarker of renal fibrosis in kidney transplantation recipients","volume":"483","author":"Luo","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"B34","first-page":"80","article-title":"Changes and clinical significance of serum human epididymal protein 4 in patients with chronic kidney disease after kidney transplantation","volume":"17","author":"Luo","year":"2020","journal-title":"CHINA Med. Her."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.4238\/2015.March.27.2","article-title":"Increased human epididymis protein 4 in benign gynecological diseases complicated with chronic renal insufficiency patients","volume":"14","author":"Lv","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1016\/s0140-6736(15)60126-x","article-title":"International society of nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): A human rights case for nephrology","volume":"385","author":"Mehta","year":"2015","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.krcp.2014.04.005","article-title":"Experimental evidence that preexisting chronic kidney disease is a risk factor for acute kidney injury","volume":"33","author":"Moo Park","year":"2014","journal-title":"Kidney Res. Clin. Pract."},{"key":"B38","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.chest.2016.04.006","article-title":"Human epididymis protein 4: A novel serum inflammatory biomarker in cystic fibrosis","volume":"150","author":"Nagy","year":"2016","journal-title":"Chest"},{"key":"B39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10741-013-9391-x","article-title":"Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: The role of natriuretic peptides and troponin","volume":"19","author":"Palazzuoli","year":"2014","journal-title":"Heart Fail Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"R94","DOI":"10.1186\/cc13864","article-title":"New insights into the mechanisms involved in B-type natriuretic peptide elevation and its prognostic value in septic patients","volume":"18","author":"Papanikolaou","year":"2014","journal-title":"Crit. Care"},{"key":"B41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.hkjn.2014.10.001","article-title":"Comparison of clinical characteristics of acute kidney injury versus acute-on-chronic renal failure: Our experience in a developing country","volume":"17","author":"Prakash","year":"2015","journal-title":"Hong Kong J. Nephrol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1213\/ane.0000000000005702","article-title":"Postoperative acute kidney injury is associated with progression of chronic kidney disease independent of severity","volume":"134","author":"Privratsky","year":"2022","journal-title":"Anesth. Analg."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1080\/14737159.2016.1251317","article-title":"Physiopathological factors affecting the diagnostic value of serum HE4-test for gynecologic malignancies","volume":"16","author":"Qu","year":"2016","journal-title":"Expert Rev. Mol. Diagn"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.4049\/jimmunol.2000281","article-title":"HE4 overexpression by ovarian cancer promotes a suppressive tumor immune microenvironment and enhanced tumor and macrophage PD-L1 expression","volume":"206","author":"Rowswell-Turner","year":"2021","journal-title":"J. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.semnephrol.2020.01.011","article-title":"Pathophysiology of AKI to CKD progression","volume":"40","author":"Sato","year":"2020","journal-title":"Semin. Nephrol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"67748","DOI":"10.18632\/oncotarget.11682","article-title":"Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease","volume":"7","author":"Wan","year":"2016","journal-title":"Oncotarget"},{"key":"B47","first-page":"508","article-title":"An applied study of B type natriuretic peptide in a non-dialysis population with chronic kidney disease","volume":"20","author":"Wang","year":"2020","journal-title":"J. Clin. Nephrol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s11255-018-1930-x","article-title":"The diagnostic value of human epididymis protein 4 as a novel biomarker in patients with renal dysfunction","volume":"50","author":"Wang","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s13258-019-00836-4","article-title":"Human epididymis protein 4 (HE4) protects against cystic pulmonary fibrosis associated-inflammation through inhibition of NF-\u03baB and MAPK singnaling","volume":"41","author":"Wang","year":"2019","journal-title":"Genes. Genomics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/ejhf.1627","article-title":"B-type natriuretic peptide trend predicts clinical significance of worsening renal function in acute heart failure","volume":"21","author":"Wettersten","year":"2019","journal-title":"Eur. J. Heart Fail"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2215\/cjn.07920713","article-title":"Epidemiology and outcomes in community-acquired versus hospital-acquired AKI","volume":"9","author":"Wonnacott","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B52","first-page":"731","article-title":"Research progress in the pathogenesis of acute renal injury to chronic kidney disease","volume":"36","author":"Xie","year":"2020","journal-title":"Chin. J. Nephrol."},{"key":"B53","first-page":"128","article-title":"Significance of serum human epididymis protein 4 levels in patients with chronic kidney disease","volume":"25","author":"Yang","year":"2016","journal-title":"J. Nephrol. Dialy Transpl."},{"key":"B54","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.xkme.2019.06.005","article-title":"Frequency and consequences of acute kidney injury in patients with CKD: A registry study in queensland Australia","volume":"1","author":"Zhang","year":"2019","journal-title":"Kidney Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12917-022-03334-0","article-title":"Serological investigation of Gyrovirus homsa1 infections in chickens in China","volume":"21","author":"Zhang","year":"2022","journal-title":"Chin. J. Blood Purif."},{"key":"B56","doi-asserted-by":"publisher","first-page":"46","DOI":"10.16305\/j.1007-1334.1985.08.035","article-title":"Treatment of azotemia by rhubarb and its mechanism","author":"Zheng","year":"1985","journal-title":"Shanghai J. Trad. Chin. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1269311\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:53:19Z","timestamp":1694393599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1269311\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":56,"alternative-id":["10.3389\/fphar.2023.1269311"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1269311","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,11]]},"article-number":"1269311"}}